Akero Therapeutics Inc. (AKRO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akero Therapeutics Inc.

    NASDAQ: AKRO · Real-Time Price · USD
    44.57
    -0.15 (-0.34%)
    At close: Sep 08, 2025, 3:59 PM
    45.00
    0.96%
    After-hours: Sep 08, 2025, 07:21 PM EDT

    Akero Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -252.06M -151.76M -112.03M -100.78M
    Depreciation & Amortization
    		 18K 29K 43K 41K
    Stock-Based Compensation
    		 29.7M 21.5M 23.24M 10.05M
    Other Working Capital
    		 990K -6.03M -5.43M 6.45M
    Other Non-Cash Items
    		 -10.76M -8.46M 689K 203K
    Deferred Income Tax
    		 n/a n/a n/a 1.07M
    Change in Working Capital
    		 3M -6.67M -4.46M 9.73M
    Operating Cash Flow
    		 -230.11M -145.37M -92.52M -79.68M
    Capital Expenditures
    		 -999K n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -516.04M -433.12M -101.45M -43.56M
    Sales Maturities Of Investments
    		 407.33M 209.5M 37.62M 85.84M
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -109.71M -223.62M -63.83M 42.28M
    Debt Repayment
    		 10M 15M 10M n/a
    Common Stock Repurchased
    		 464K n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 12.77M 2.89M 4.43M n/a
    Financial Cash Flow
    		 445.85M 353.32M 255.63M 602K
    Net Cash Flow
    		 106.03M -15.67M 99.29M -36.8M
    Free Cash Flow
    		 -230.11M -145.37M -92.52M -79.68M

    Add to Watchlist